Maximizing current treatment options: exploring psychological barriers to change
نویسندگان
چکیده
منابع مشابه
Zenker's diverticulum: exploring treatment options
Zenker's diverticulum is an acquired sac-like outpouching of the mucosa and submucosa layers located dorsally at the pharyngoesophageal junction through Killian's dehiscence. It is the most common type of oesophageal diverticula with a reported prevalence ranging between 0.01 to 0.11% and typically occurs in middle-aged and elderly patients. Predominant symptoms are dysphagia and regurgitation....
متن کاملHand dermatitis: current treatment options.
Avoidance advice: This forms a very important component of treatment once a diagnosis of contact dermatitis has been made on the basis of a detailed history, examination and patch testing. Possible sources of exposure to the causative allergens should be identified and advice has to be tailored to an individual. The patient should be informed about the identification of the offending agent and ...
متن کاملTackling sleeplessness: Psychological treatment options for insomnia
The purpose of the present paper is to review and summarize the research supporting nonpharmacologic treatment options for insomnia. The different treatment approaches are described followed by a review of both original research articles and meta-analyses. Meta-analytic reviews suggest that common nonpharmacologic approaches exert, on average, medium to large effect sizes on SOL, WASO, NWAK, SQ...
متن کاملExploring treatment options for rotator cuff disorders
Successful management of rotator cuff disorders requires a diagnostic and treatment algorithm that takes comorbidities into consideration. Within a framework of the patient’s age, the tear size, the injury mechanism, chronicity, and muscle atrophy/fatty infiltration, the overall risk of irreversible changes to the cuff with continued nonoperative treatment is weighed against the potential for i...
متن کاملTreatment options in Alzheimer's disease: maximizing benefit, managing expectations.
Alzheimer's disease (AD) is becoming an increasingly heavy burden on the society of developed countries, and physicians now face the challenge of providing efficient treatment regimens to an ever-higher number of individuals affected by the disease. Currently approved anti-AD therapies - the cholinesterase inhibitors and the N-methyl-D-aspartate receptor antagonist memantine - offer modest symp...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: European Heart Journal Supplements
سال: 2005
ISSN: 1554-2815,1520-1554
DOI: 10.1093/eurheartj/sui030